Latest filing published 11 Sept 2019 for Lannett Co INC, €184k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Albert Paonessa III: trading record in brief
Albert Paonessa III has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Watson Pharmaceuticals Inc, Lannett Co Inc and Andrx Corp /DE/. The record holds 43 filings, for trades running from 1 January 2006 to 9 September 2019.
In open-market terms, that means 2 purchases worth €99k on one side and 10 sales worth €3.6M on the other. Taken together, the sales exceed the purchases by €3.5M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 28 share grants. 2019 to date brings no purchases and 2 sales.
The latest filing, published on 11 September 2019, reports an open-market sale of €184k in Lannett Co Inc. The latest purchase dates back some time: it was published 2,886 days ago, on 14 December 2018. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Albert Paonessa III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,195 shares@ US$12.5447.0% of flowCommon StockSEC:0001209191-19-049151:0
- 11,582 shares@ US$10.3027.6% of flowCommon StockSEC:0001209191-19-048737:0
- 33,445 shares0Common StockSEC:0001209191-19-042883:0
- 10,000 shares@ US$5.0711.4% of flowCommon StockSEC:0001209191-18-062603:0Canonical exit: 13 Mar 2019 (T+90)
- 16,195 shares0Common StockSEC:0001209191-18-043642:0
- 6,977 shares0Common StockSEC:0001209191-17-046224:0
- 4,075 shares0Common StockSEC:0001209191-16-133858:0
- 2,500 shares@ US$24.57100.0% of flowCommon StockSEC:0001209191-16-096371:0Canonical exit: 5 May 2016 (T+90)
- 6,642 shares@ US$230.49Ordinary Shares, par value $0.0001SEC:0001179110-14-014054:0
- 6,500 shares@ US$158.75Ordinary SharesSEC:0001179110-13-016516:0
- 33,729 sharesOrdinary SharesSEC:0001179110-13-015205:0
- 16,760 sharesCommon Stock, par value $0.0033SEC:0001179110-13-015057:0
- 16,843 shares@ US$144.00Common Stock, par value $0.0033SEC:0001179110-13-015057:1
- 33,729 sharesCommon Stock, par value $0.0033SEC:0001179110-13-015057:2
- 5,476 shares@ US$135.89Common Stock, par value $0.0033SEC:0001179110-13-013286:0
- 3,537 shares0Common Stock, par value $0.0033SEC:0001179110-13-004746:0
- 2,494 shares0Common Stock, par value $0.0033SEC:0001179110-13-004746:1
- 1,825 shares@ US$86.46Common Stock, par value $0.0033SEC:0001179110-13-004507:0
- 2,028 shares@ US$85.54Common Stock, par value $0.0033SEC:0001179110-13-004337:0
- 4,413 shares@ US$86.05Common Stock, par value $0.0033SEC:0001179110-13-004337:1
- 4,000 shares@ US$72.77Common Stock, par value $0.0033SEC:0001179110-12-008035:0
- 1,587 shares@ US$59.21Common Stock, par value $0.0033SEC:0001179110-12-005198:0
- 4,457 shares0Common Stock, par value $0.0033SEC:0001179110-12-004798:0
- 3,421 shares0Common Stock, par value $0.0033SEC:0001179110-12-004798:1
- 1,782 shares@ US$58.17Common Stock, par value $0.0033SEC:0001179110-12-003653:0
25 of 42 declarations
